AstrazenecaAZN
13F holders, Q3 2025 (September 30)7holders +2
2new positions
0sold out
$135.40avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Astrazeneca PLC (AZN) in their 13F filings, up 2 from Q2 2025. 2 opened new positions and 0 sold out. The largest holders were Boston Common Asset Management, LLC ($29.0M), Old Mission Capital LLC ($4.6M) and FNY Investment Advisers, LLC ($2.2M).
- Company
- Astrazeneca PLC
- CUSIP
- G0593M107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $888K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 72,274 shares bought, net +72,274 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Boston Common Asset Management, LLC | 0.81% | Add +5.6% | 192,589 | $29.0M |
| Old Mission Capital LLC | 0.16% | Add +881.2% | 59,639 | $4.6M |
| FNY Investment Advisers, LLC | 0.74% | No change | 200 | $2.2M |
| SWP Investment Management LLC | 2.16% | Add +9.8% | 28,596 | $2.2M |
| Saranac Partners Ltd | 0.18% | New | 5,817 | $876K |
| Raffa Wealth Management, LLC | 0.01% | Add +10.3% | 418 | $32K |
| Principia Wealth Advisory, LLC | 0.01% | New | 162 | $12K |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC the manager owns.